Company / CapEx per Share
Tandem Diabetes Care CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.30
FY2025
5-year range
$0.29 / $0.43
FY2021-FY2025
Trend
+2.6%
vs FY2024
Sector context
#101 of 148
Health Care
What the data says
At $0.30, Tandem Diabetes Care's capex per share ranks #101 of 148 in the Health Care sector. CapEx per Share returned to growth in FY2025 after 2 years of decline, reaching $0.30.
Based on SEC 10-K filings.
0.30 in FY2025 with a 5-year CAGR of +43.0%.
Declined from $0.42 to $0.30 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -11.2%
- 5-Year CAGR
- +43.0%
- 10-Year CAGR
- -
Sector benchmark
#101 of 148 in Health CareTop 68% of 148This company $0.30 Sector average $1.67
▼
-82.0% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 2.6% year-over-year.
- Ranks #101 out of 148 companies in the Health Care sector.
- Peak capex per share was recorded in FY2017.
- Lowest capex per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.30 | +2.6% |
| FY2024 | $0.29 | -29.4% |
| FY2023 | $0.42 | -3.2% |
| FY2022 | $0.43 | +37.0% |
| FY2021 | $0.31 | +523.6% |
| FY2020 | $0.05 | -49.4% |
| FY2019 | $0.10 | -88.7% |
| FY2018 | $0.88 | -52.4% |
| FY2017 | $1.85 | +527.9% |
| FY2016 | $0.30 | +21.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026